secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigilon Therapeutics, Inc. (—)
CIK:        0001821323
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001558370-22-018890
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigilon Therapeutics receives Nasdaq delisting notice for bid price non-compliance; will request hearing
--------------------------------------------------------------------------------

- Nasdaq notified Sigilon on Dec 20, 2022 that its common stock will be delisted from the Nasdaq Global Select Market.
- Delisting stems from failure to maintain minimum $1.00 bid price after 180-day grace period ended Dec 19, 2022.
- Company intends to timely request a hearing before the Nasdaq Hearings Panel, which will stay delisting pending decision.
- No assurance that the Panel will grant continued listing or that Sigilon can regain compliance within any granted period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821323/000155837022018890/0001558370-22-018890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821323/000155837022018890/sgtx-20221220x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer